MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1

Abstract Background MicroRNAs (miRNAs) play crucial roles in the development of various cancers. Here, we aimed to evaluate the roles of miR‐138‐5p in lung cancer progression and the value of miR‐138‐5p in lung cancer diagnosis. Methods Quantitative real‐time PCR was performed to examine the express...

Full description

Bibliographic Details
Main Authors: Jiaen Wu, Xuejia Han, Xiancong Yang, Youjie Li, Yan Liang, Guangbin Sun, Ranran Wang, Pingyu Wang, Shuyang Xie, Jiankai Feng, Hongfang Sun
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14791
_version_ 1797894398434869248
author Jiaen Wu
Xuejia Han
Xiancong Yang
Youjie Li
Yan Liang
Guangbin Sun
Ranran Wang
Pingyu Wang
Shuyang Xie
Jiankai Feng
Hongfang Sun
author_facet Jiaen Wu
Xuejia Han
Xiancong Yang
Youjie Li
Yan Liang
Guangbin Sun
Ranran Wang
Pingyu Wang
Shuyang Xie
Jiankai Feng
Hongfang Sun
author_sort Jiaen Wu
collection DOAJ
description Abstract Background MicroRNAs (miRNAs) play crucial roles in the development of various cancers. Here, we aimed to evaluate the roles of miR‐138‐5p in lung cancer progression and the value of miR‐138‐5p in lung cancer diagnosis. Methods Quantitative real‐time PCR was performed to examine the expressions of miR‐138‐5p and smad nuclear interacting protein 1 (SNIP1) mRNA. The diagnostic value of miR‐138‐5p was analyzed using receiver operating characteristic (ROC) curve analysis, sensitivity, and specificity. We explored the effect of miR‐138‐5p on cell proliferation and metastasis by CCK‐8, colony formation, wound healing and transwell assays. Western blot was employed to detect the protein expression of SNIP1 and related genes. Lung cancer cell growth was evaluated in vivo using xenograft tumor assay. Results MiR‐138‐5p was decreased in the serum of patients with non‐small cell lung cancer (NSCLC) and in NSCLC cells and tissues. The area under the ROC curve of serum miR‐138‐5p in the diagnosis of NSCLC was 0.922. This finding indicates the high diagnostic efficiency for lung cancer. MiR‐138‐5p suppressed but its inhibitor promoted cell proliferation and migration compared with control treatment in vitro and in vivo. MiR‐138‐5p directly binds to the 3′‐untranslated region of SNIP1 and negatively regulated the expression of SNIP1, thereby inhibiting the expression of cyclin D1 and c‐Myc. Moreover, overexpression of SNIP1 rescues the miR‐138‐5p‐mediated inhibition in NSCLC cells. Conclusions The results suggested that miR‐138‐5p suppressed lung cancer cell proliferation and migration by targeting SNIP1. Serum miR‐138‐5p is a novel and valuable biomarker for NSCLC diagnosis.
first_indexed 2024-04-10T07:08:25Z
format Article
id doaj.art-6c0f0b55b02d4cdbb0693cf5ff4f099a
institution Directory Open Access Journal
issn 1759-7706
1759-7714
language English
last_indexed 2024-04-10T07:08:25Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj.art-6c0f0b55b02d4cdbb0693cf5ff4f099a2023-02-27T01:36:59ZengWileyThoracic Cancer1759-77061759-77142023-02-0114661262310.1111/1759-7714.14791MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1Jiaen Wu0Xuejia Han1Xiancong Yang2Youjie Li3Yan Liang4Guangbin Sun5Ranran Wang6Pingyu Wang7Shuyang Xie8Jiankai Feng9Hongfang Sun10Department of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaDepartment of Laboratory Medicine Yantai Affiliated Hospital of Binzhou Medical University Yantai ChinaDepartment of Biochemistry and Molecular Biology Binzhou Medical University Yantai ChinaAbstract Background MicroRNAs (miRNAs) play crucial roles in the development of various cancers. Here, we aimed to evaluate the roles of miR‐138‐5p in lung cancer progression and the value of miR‐138‐5p in lung cancer diagnosis. Methods Quantitative real‐time PCR was performed to examine the expressions of miR‐138‐5p and smad nuclear interacting protein 1 (SNIP1) mRNA. The diagnostic value of miR‐138‐5p was analyzed using receiver operating characteristic (ROC) curve analysis, sensitivity, and specificity. We explored the effect of miR‐138‐5p on cell proliferation and metastasis by CCK‐8, colony formation, wound healing and transwell assays. Western blot was employed to detect the protein expression of SNIP1 and related genes. Lung cancer cell growth was evaluated in vivo using xenograft tumor assay. Results MiR‐138‐5p was decreased in the serum of patients with non‐small cell lung cancer (NSCLC) and in NSCLC cells and tissues. The area under the ROC curve of serum miR‐138‐5p in the diagnosis of NSCLC was 0.922. This finding indicates the high diagnostic efficiency for lung cancer. MiR‐138‐5p suppressed but its inhibitor promoted cell proliferation and migration compared with control treatment in vitro and in vivo. MiR‐138‐5p directly binds to the 3′‐untranslated region of SNIP1 and negatively regulated the expression of SNIP1, thereby inhibiting the expression of cyclin D1 and c‐Myc. Moreover, overexpression of SNIP1 rescues the miR‐138‐5p‐mediated inhibition in NSCLC cells. Conclusions The results suggested that miR‐138‐5p suppressed lung cancer cell proliferation and migration by targeting SNIP1. Serum miR‐138‐5p is a novel and valuable biomarker for NSCLC diagnosis.https://doi.org/10.1111/1759-7714.14791biomarkerlung cancermiR‐138‐5pSNIP1tumor suppressor
spellingShingle Jiaen Wu
Xuejia Han
Xiancong Yang
Youjie Li
Yan Liang
Guangbin Sun
Ranran Wang
Pingyu Wang
Shuyang Xie
Jiankai Feng
Hongfang Sun
MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1
Thoracic Cancer
biomarker
lung cancer
miR‐138‐5p
SNIP1
tumor suppressor
title MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1
title_full MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1
title_fullStr MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1
title_full_unstemmed MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1
title_short MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1
title_sort mir 138 5p suppresses the progression of lung cancer by targeting snip1
topic biomarker
lung cancer
miR‐138‐5p
SNIP1
tumor suppressor
url https://doi.org/10.1111/1759-7714.14791
work_keys_str_mv AT jiaenwu mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT xuejiahan mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT xiancongyang mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT youjieli mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT yanliang mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT guangbinsun mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT ranranwang mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT pingyuwang mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT shuyangxie mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT jiankaifeng mir1385psuppressestheprogressionoflungcancerbytargetingsnip1
AT hongfangsun mir1385psuppressestheprogressionoflungcancerbytargetingsnip1